KEGG   Lipotes vexillifer (Yangtze River dolphin): 103083209
Entry
103083209         CDS       T03090                                 
Symbol
MAPK11
Name
(RefSeq) mitogen-activated protein kinase 11
  KO
K04441  p38 MAP kinase [EC:2.7.11.24]
Organism
lve  Lipotes vexillifer (Yangtze River dolphin)
Pathway
lve01522  Endocrine resistance
lve04010  MAPK signaling pathway
lve04015  Rap1 signaling pathway
lve04068  FoxO signaling pathway
lve04071  Sphingolipid signaling pathway
lve04114  Oocyte meiosis
lve04148  Efferocytosis
lve04218  Cellular senescence
lve04261  Adrenergic signaling in cardiomyocytes
lve04370  VEGF signaling pathway
lve04380  Osteoclast differentiation
lve04550  Signaling pathways regulating pluripotency of stem cells
lve04611  Platelet activation
lve04613  Neutrophil extracellular trap formation
lve04620  Toll-like receptor signaling pathway
lve04621  NOD-like receptor signaling pathway
lve04622  RIG-I-like receptor signaling pathway
lve04625  C-type lectin receptor signaling pathway
lve04657  IL-17 signaling pathway
lve04658  Th1 and Th2 cell differentiation
lve04659  Th17 cell differentiation
lve04660  T cell receptor signaling pathway
lve04664  Fc epsilon RI signaling pathway
lve04668  TNF signaling pathway
lve04670  Leukocyte transendothelial migration
lve04714  Thermogenesis
lve04722  Neurotrophin signaling pathway
lve04723  Retrograde endocannabinoid signaling
lve04728  Dopaminergic synapse
lve04750  Inflammatory mediator regulation of TRP channels
lve04912  GnRH signaling pathway
lve04914  Progesterone-mediated oocyte maturation
lve04917  Prolactin signaling pathway
lve04926  Relaxin signaling pathway
lve04932  Non-alcoholic fatty liver disease
lve04933  AGE-RAGE signaling pathway in diabetic complications
lve04935  Growth hormone synthesis, secretion and action
lve04936  Alcoholic liver disease
lve05014  Amyotrophic lateral sclerosis
lve05020  Prion disease
lve05022  Pathways of neurodegeneration - multiple diseases
lve05132  Salmonella infection
lve05133  Pertussis
lve05135  Yersinia infection
lve05140  Leishmaniasis
lve05142  Chagas disease
lve05145  Toxoplasmosis
lve05152  Tuberculosis
lve05161  Hepatitis B
lve05163  Human cytomegalovirus infection
lve05167  Kaposi sarcoma-associated herpesvirus infection
lve05169  Epstein-Barr virus infection
lve05170  Human immunodeficiency virus 1 infection
lve05171  Coronavirus disease - COVID-19
lve05205  Proteoglycans in cancer
lve05208  Chemical carcinogenesis - reactive oxygen species
lve05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
lve05415  Diabetic cardiomyopathy
lve05417  Lipid and atherosclerosis
lve05418  Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:lve00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    103083209 (MAPK11)
   04015 Rap1 signaling pathway
    103083209 (MAPK11)
   04370 VEGF signaling pathway
    103083209 (MAPK11)
   04668 TNF signaling pathway
    103083209 (MAPK11)
   04068 FoxO signaling pathway
    103083209 (MAPK11)
   04071 Sphingolipid signaling pathway
    103083209 (MAPK11)
 09140 Cellular Processes
  09141 Transport and catabolism
   04148 Efferocytosis
    103083209 (MAPK11)
  09143 Cell growth and death
   04114 Oocyte meiosis
    103083209 (MAPK11)
   04218 Cellular senescence
    103083209 (MAPK11)
  09144 Cellular community - eukaryotes
   04550 Signaling pathways regulating pluripotency of stem cells
    103083209 (MAPK11)
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    103083209 (MAPK11)
   04613 Neutrophil extracellular trap formation
    103083209 (MAPK11)
   04620 Toll-like receptor signaling pathway
    103083209 (MAPK11)
   04621 NOD-like receptor signaling pathway
    103083209 (MAPK11)
   04622 RIG-I-like receptor signaling pathway
    103083209 (MAPK11)
   04625 C-type lectin receptor signaling pathway
    103083209 (MAPK11)
   04660 T cell receptor signaling pathway
    103083209 (MAPK11)
   04658 Th1 and Th2 cell differentiation
    103083209 (MAPK11)
   04659 Th17 cell differentiation
    103083209 (MAPK11)
   04657 IL-17 signaling pathway
    103083209 (MAPK11)
   04664 Fc epsilon RI signaling pathway
    103083209 (MAPK11)
   04670 Leukocyte transendothelial migration
    103083209 (MAPK11)
  09152 Endocrine system
   04912 GnRH signaling pathway
    103083209 (MAPK11)
   04914 Progesterone-mediated oocyte maturation
    103083209 (MAPK11)
   04917 Prolactin signaling pathway
    103083209 (MAPK11)
   04926 Relaxin signaling pathway
    103083209 (MAPK11)
   04935 Growth hormone synthesis, secretion and action
    103083209 (MAPK11)
  09153 Circulatory system
   04261 Adrenergic signaling in cardiomyocytes
    103083209 (MAPK11)
  09156 Nervous system
   04728 Dopaminergic synapse
    103083209 (MAPK11)
   04723 Retrograde endocannabinoid signaling
    103083209 (MAPK11)
   04722 Neurotrophin signaling pathway
    103083209 (MAPK11)
  09157 Sensory system
   04750 Inflammatory mediator regulation of TRP channels
    103083209 (MAPK11)
  09158 Development and regeneration
   04380 Osteoclast differentiation
    103083209 (MAPK11)
  09159 Environmental adaptation
   04714 Thermogenesis
    103083209 (MAPK11)
 09160 Human Diseases
  09161 Cancer: overview
   05205 Proteoglycans in cancer
    103083209 (MAPK11)
   05208 Chemical carcinogenesis - reactive oxygen species
    103083209 (MAPK11)
   05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
    103083209 (MAPK11)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    103083209 (MAPK11)
   05161 Hepatitis B
    103083209 (MAPK11)
   05171 Coronavirus disease - COVID-19
    103083209 (MAPK11)
   05163 Human cytomegalovirus infection
    103083209 (MAPK11)
   05167 Kaposi sarcoma-associated herpesvirus infection
    103083209 (MAPK11)
   05169 Epstein-Barr virus infection
    103083209 (MAPK11)
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    103083209 (MAPK11)
   05135 Yersinia infection
    103083209 (MAPK11)
   05133 Pertussis
    103083209 (MAPK11)
   05152 Tuberculosis
    103083209 (MAPK11)
  09174 Infectious disease: parasitic
   05145 Toxoplasmosis
    103083209 (MAPK11)
   05140 Leishmaniasis
    103083209 (MAPK11)
   05142 Chagas disease
    103083209 (MAPK11)
  09164 Neurodegenerative disease
   05014 Amyotrophic lateral sclerosis
    103083209 (MAPK11)
   05020 Prion disease
    103083209 (MAPK11)
   05022 Pathways of neurodegeneration - multiple diseases
    103083209 (MAPK11)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    103083209 (MAPK11)
   05418 Fluid shear stress and atherosclerosis
    103083209 (MAPK11)
   05415 Diabetic cardiomyopathy
    103083209 (MAPK11)
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    103083209 (MAPK11)
   04932 Non-alcoholic fatty liver disease
    103083209 (MAPK11)
   04933 AGE-RAGE signaling pathway in diabetic complications
    103083209 (MAPK11)
  09176 Drug resistance: antineoplastic
   01522 Endocrine resistance
    103083209 (MAPK11)
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01001 Protein kinases [BR:lve01001]
    103083209 (MAPK11)
Enzymes [BR:lve01000]
 2. Transferases
  2.7  Transferring phosphorus-containing groups
   2.7.11  Protein-serine/threonine kinases
    2.7.11.24  mitogen-activated protein kinase
     103083209 (MAPK11)
Protein kinases [BR:lve01001]
 Serine/threonine kinases: CMGC group
  MAPK family [OT]
   103083209 (MAPK11)
SSDB
Motif
Pfam: Pkinase PK_Tyr_Ser-Thr ABC1 Kdo APH Cas_CT1975 Kinase-like FTA2
Other DBs
NCBI-GeneID: 103083209
NCBI-ProteinID: XP_007454143
UniProt: A0A340WXR5
LinkDB
Position
Unknown
AA seq 350 aa
MSEHALGVPPVKGQAALGSGRPPCSSAYDTRLRQRVAVKKLSRPFQSLIHARRTYRELRL
LKHLKHENVIGLLDVFTPATSLEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL
LRGLKYIHSAGIIHRDLKPSNLAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEIM
LNWMHYNQTVDIWSVGCIMAELLQGKALFPGNDYIDQLKRIMEVVGTPSPEVLAKISSEH
ARTYIQSLPHMPQKDLRSIFHGANPLAVDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP
EDEPEAEPYDESVEAKERTVEEWKELTYQEVLSFKPPEPPQPPGSLDVKQ
NT seq 1053 nt   +upstreamnt  +downstreamnt
atgtctgagcatgcattgggggtgcccccggtcaagggccaggcagccctgggctctggc
aggccgccttgcagctcagcctacgacacgcggctgcgccagagggtggcggtgaagaaa
ctgtcgcgccccttccagtcgctcatccacgcgcggaggacgtaccgcgagctgcggctg
ctcaagcacctgaagcacgagaacgtcatcgggctgctggacgtgttcacgccggccacc
tccctcgaggacttcagcgaagtgtacctggtgaccacgctgatgggcgccgacctgaac
aacatcgtcaagtgccaggcgctgagcgacgagcacgttcagttcctcgtgtaccagctg
ctgcgcgggctgaagtacatccactcggcggggatcatccaccgggacctgaagcccagc
aacttggctgtgaacgaggactgcgagctgcggatcctggactttgggcttgcgcgccag
gcggacgaggagatgactggctacgtggccacgcgctggtaccgggcccctgagatcatg
ctgaactggatgcactacaaccagacagtggacatctggtctgtgggctgcatcatggcc
gagctgctccagggaaaggcccttttcccaggaaatgactacatcgaccagctgaagcgc
atcatggaggtggtgggcacacccagccctgaagttctggcaaagatatcgtcagaacat
gcccggacctacatccagtccctgccccacatgccccagaaggacctcaggagcatcttc
catggagccaaccccctggctgtggacctcctgggaaggatgctggtgctggacagtgac
cagagggtcagtgcagccgaggccctggcccatgcctacttcagccagtaccacgacccc
gaggatgagcccgaggccgagccctacgacgaaagcgttgaggccaaggagcgcacagtg
gaggagtggaaggagctcacctaccaggaagtcctcagcttcaagcccccagagccaccg
cagccgcctggcagcctggacgttaagcagtga

DBGET integrated database retrieval system